Top 10 Generic Company Globally in 2018 (by revenue)
Here you can preview top 10 global generic companies by revenue. Data is presented in USD million. Click here to view the... Read More
Take a self competency test in authorized generics
In the U.S., prescription drugs approved by the federal Food and Drug Administration (FDA) are granted a specified period of market exclusivity,... Read More
Health Canada approves Biocon and Mylan’s trastuzumab biosimilar ‘Ogivri’ for HER2-positive cancers
Biocon and Mylan have received the clearance from Health Canada for the latter’s biosimilar Herceptin: trastuzumab co-developed under the brand name Ogivri... Read More
Case Study – A close look into Eli Lilly’s pricing strategy for Insulin Lispro injection in US market
Eli Lilly and Company’s has announced that its Insulin Lispro Injection is now available for order in pharmacies for people who use... Read More
Sandoz licensing agreement with EirGenix to commercialize trastuzumab biosimilar
Posted on02 May 2019
TagsBiosimilar, biosimilar deals, biosimilar of sandoz, drug licensing, EirGenix, sandoz, trastuzumab
Comments0
Sandoz, a Novartis division and a global leader in biosimilars, has entered into an agreement to commercialize a proposed trastuzumab biosimilar. This... Read More
Drug Department asking for documents to be notarizerd. What does it means? How documents should be notarized?
Notary means a person authorized to perform certain legal formalities, especially to draw up or certify contracts, deeds, and other documents for... Read More
Roche to launch emicizumab (Hemlibra) in India for people with haemophilia A on World Haemophilia Day
Roche announced that emicizumab (Hemlibra) has been approved in India for haemophilia A with factor VIII inhibitors. It is indicated as a... Read More
Check Your Competency in Data Integrity
Data Integrity refers to maintaining and assuring the accuracy and consistency of data over its entire product life-cycle. Over the last few years several, FDA... Read More
Adalimumab Biosimilar Litigation: Sandoz’s settlement with AbbVie
Sandoz, a Novartis division and the global leader in biosimilars, announced a global resolution of all intellectual property (IP) related litigation with... Read More
Tildrakizumab (Ilumetri): Discovery, Development to Commercialization Case Study
Brand Name: Ilumetri Biomolecule: Tildrakizumab Tildrakizumab was designed to block interleukin-23, a cytokine that plays an important role in managing the immune... Read More